UK markets closed

Lyra Therapeutics, Inc. (LYRA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.22-0.31 (-4.75%)
At close: 04:00PM EDT
6.50 +0.28 (+4.50%)
After hours: 05:28PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 371.30M
Enterprise value 295.43M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)198.67
Price/book (mrq)4.15
Enterprise value/revenue 189.62
Enterprise value/EBITDA -4.53

Trading information

Stock price history

Beta (5Y monthly) 0.20
52-week change 3209.45%
S&P500 52-week change 327.86%
52-week high 36.79
52-week low 31.93
50-day moving average 35.34
200-day moving average 34.13

Share statistics

Avg vol (3-month) 3312.41k
Avg vol (10-day) 3569.14k
Shares outstanding 559.74M
Implied shares outstanding 659.74M
Float 826.2M
% held by insiders 11.18%
% held by institutions 184.65%
Shares short (15 Mar 2024) 4206.27k
Short ratio (15 Mar 2024) 40.62
Short % of float (15 Mar 2024) 40.51%
Short % of shares outstanding (15 Mar 2024) 40.35%
Shares short (prior month 15 Feb 2024) 4185.43k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-11,285.62%

Management effectiveness

Return on assets (ttm)-32.43%
Return on equity (ttm)-73.67%

Income statement

Revenue (ttm)1.56M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)1,227.30%
Gross profit (ttm)N/A
EBITDA -65.25M
Net income avi to common (ttm)-62.68M
Diluted EPS (ttm)-1.26
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)102.75M
Total cash per share (mrq)1.72
Total debt (mrq)26.88M
Total debt/equity (mrq)30.06%
Current ratio (mrq)5.35
Book value per share (mrq)1.56

Cash flow statement

Operating cash flow (ttm)-63.3M
Levered free cash flow (ttm)-33.73M